Patent · US Active

Antibody formulations and methods

US10517830B2 · kind B2 · utility

0Cited by

112References

9Claims

0Family size

Assignee

Prothena Biosciences Limited · IE

Inventors

Patrick Garidel · Norderstedt, DE
Isaac Craig HENDERSON · San Francisco, US
Pamela KLEIN · San Mateo, US

Key dates

Filing date	Jan 11, 2018
Grant date	Dec 31, 2019
Priority date	—
Expiry date	Jan 11, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibody formulations and methods useful for prophylaxis or treatment of amyloidosis, including AA amyloidosis and AL amyloidosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.